CD274 and neoplasm: It was demonstrated that fluorescent multiplex immunohistochemistry (mIHC/IF) alone, outperforms PDL1 immunohistochemistry, immune signatures and tumor mutational burden in terms of sensitivity and positive predictive value for prediction of response to ICI [31].